Back
Match Group Inc. - Ordinary Shares - New Vs. Akero Therapeutics Industry Stock Comparison
Buy
84
MTCH
Match Group Inc. - Ordinary Shares - New
Last Price:
$38.29
Seasonality Move:
-1.13%
Sell
37
AKRO
Akero Therapeutics
Last Price:
$49.43
Seasonality Move:
26.87%
Buy
84
Match Group Inc. - Ordinary Shares - New (MTCH)
is a Buy
Is Match Group Inc. - Ordinary Shares - New a Buy, Sell or Hold?
-
The current Match Group Inc. - Ordinary Shares - New [MTCH] share price is $38.28. The Score for MTCH is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
MTCH is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
37
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $49.38. The Score for AKRO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MTCH Stock Price Chart
What is Match Group Inc. - Ordinary Shares - New's stock price today?
-
The Match Group Inc. - Ordinary Shares - New share price today is $38.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTCH is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $49.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
MTCH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.34 | Buy |
Relative Strength Index (14 RSI): | 69.84 | Buy |
Chaikin Money Flow: | -3116326 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.62 - 36.64) | Buy |
Bollinger Bands (100): | (28.94 - 33.8) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 47.31 | Sell |
Chaikin Money Flow: | 1491006 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.44 - 52.22) | Sell |
Bollinger Bands (100): | (40.88 - 53.18) | Buy |
MTCH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.19 | Buy |
20-day SMA: | 35.23 | Buy |
50-day SMA: | 33.06 | Buy |
200-day SMA: | 32.1 | Buy |
8-day EMA: | 36.14 | Buy |
20-day EMA: | 27.47 | Buy |
50-day EMA: | 15.47 | Buy |
200-day EMA: | 4.69 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.72 | Sell |
20-day SMA: | 49.69 | Sell |
50-day SMA: | 51.97 | Sell |
200-day SMA: | 41.9 | Buy |
8-day EMA: | 49.36 | Buy |
20-day EMA: | 49.88 | Sell |
50-day EMA: | 49.93 | Sell |
200-day EMA: | 43.03 | Buy |
Match Group Inc. - Ordinary Shares - New Earnings Growth & MTCH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.18 per share, an increase this year of $0.23 per share, and an increase next year of $0.54 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.
Match Group Inc. - Ordinary Shares - New Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |